Pancreatic Cancer Research

ResearcherTokushima UniversityActive in the last 2 years

Masanori Takehara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9024-4900; OpenAlex author ID A5083408015. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Exosomal miR-199a-3p Secreted From Cancer-Associated Adipocytes Promotes Pancreatic Cancer Progression. Co-author DOI 10.1002/cam4.70265↗
  2. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression. Co-author DOI 10.1111/cas.14527↗
  3. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1159/000503225↗
  4. A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1007/s00280-015-2835-3↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tetsuji Takayama · 4 shared papers, 2015–2024 · strength 0.41
  2. Kazuyoshi Noda · 2 shared papers, 2020–2024 · strength 0.28
  3. Yasuyuki Okada · 2 shared papers, 2015–2024 · strength 0.22
  4. Jun Okazaki · 2 shared papers, 2015–2020 · strength 0.13
  5. Tetsuya Ikemoto · 1 shared paper, 2020 · strength 0.10
  6. Mitsuo Shimada · 1 shared paper, 2020 · strength 0.10
  7. Takahiro Goji · 1 shared paper, 2015 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.